Project supported by the Health Department of Zhejiang Province(No. 2004A040);the Education Department of Zhejiang Province (No. G20030486), China
Background: Allogeneic blood transfusion-induced immunomodulation (TRIM) and its adverse effect on the prognosis of patients treated surgically for cancer remain complex and controversial. However, the potential ri...